Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1102 of 1,261
  1. US 7109323

    Formulation of boronic acid compounds

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Sep 19, 2006 Β· Expires Sep 14, 2026

    granted
  2. US 7109303

    Modified cytokines for use in cancer therapy

    FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR Β· Granted Sep 19, 2006 Β· Expires Sep 14, 2026

    granted
  3. US 7109210

    Quinuclidine derivatives and medicinal compositions containing the same

    Almirall Prodesfarma S.A. Β· Granted Sep 19, 2006 Β· Expires Sep 14, 2026

    granted
  4. US 7109172

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated Β· Granted Sep 19, 2006 Β· Expires Sep 14, 2026

    granted
  5. US 7105156

    Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells

    The Regents of the University of California Β· Granted Sep 12, 2006 Β· Expires Sep 7, 2026

    granted
  6. US 7105183

    Chlorite in the treatment of neurodegenerative disease

    The Regents of the University of California Β· Granted Sep 12, 2006 Β· Expires Sep 7, 2026

    granted
  7. US 7105546

    Acyclic and cyclic amine derivatives

    Vertex Pharmaceuticals Incorporated Β· Granted Sep 12, 2006 Β· Expires Sep 7, 2026

    granted
  8. US 7105641

    MCP-1 receptor antibodies

    The Regents of the University of California Β· Granted Sep 12, 2006 Β· Expires Sep 7, 2026

    granted
  9. US 7105488

    G protein-coupled receptor antagonists

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Sep 12, 2006 Β· Expires Sep 7, 2026

    granted
  10. US 7105171

    Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia

    The Regents of the University of California Β· Granted Sep 12, 2006 Β· Expires Sep 7, 2026

    granted
  11. US 7105170

    Latent human tuberculosis model, diagnostic antigens, and methods of use

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Sep 12, 2006 Β· Expires Sep 7, 2026

    granted
  12. US 7105330

    Human plasma hyaluronidase

    The Regents of the University of California Β· Granted Sep 12, 2006 Β· Expires Sep 7, 2026

    granted
  13. US 7105169

    Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Sep 12, 2006 Β· Expires Sep 7, 2026

    granted
  14. US 7105572

    Stable emulsion compositions

    Takeda Pharmaceutical Company Limited Β· Granted Sep 12, 2006 Β· Expires Sep 7, 2026

    granted
  15. US 7105695

    Synthesis of combretastatin A-2 prodrugs

    ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Sep 12, 2006 Β· Expires Sep 7, 2026

    granted
  16. US 7105643

    Monoclonal antibodies specific for crack cocaine metabolites, a cell line producing the same, and crack cocaine conjugates

    The United States of America as represented by the Attorney General of the Dept. of Justice Β· Granted Sep 12, 2006 Β· Expires Sep 7, 2026

    granted
  17. US 7105561

    Use of etodolac for the treatment of prostate cancer

    The Regents of the University of California Β· Granted Sep 12, 2006 Β· Expires Sep 7, 2026

    granted
  18. US 7105560

    Use of etodolac in the treatment of multiple myeloma

    The Regents of the University of California Β· Granted Sep 12, 2006 Β· Expires Sep 7, 2026

    granted
  19. US 7105514

    Substituted indolealkanoic acids

    The Institute for Dibetes Discovery LLC Β· Granted Sep 12, 2006 Β· Expires Sep 7, 2026

    granted
  20. US 7105496

    Methods and compositions for inhibiting angiogenesis

    Northwestern University Β· Granted Sep 12, 2006 Β· Expires Sep 7, 2026

    granted
  21. US 7105558

    Gastrin and cholecystokinin receptor lignads (iv)

    The James Black Foundation Limited Β· Granted Sep 12, 2006 Β· Expires Sep 7, 2026

    granted
  22. US 7102059

    DNA molecules and polypeptides of Pseudomonas syringae Hrp pathogenicity island and their uses

    The Board of Regents University Community College System of Nevada on Behalf of the University of Nevada-Las Vegas Β· Granted Sep 5, 2006 Β· Expires Aug 31, 2026

    granted
  23. US 7101909

    Calcium channel drugs and uses

    Theravance, Inc. Β· Granted Sep 5, 2006 Β· Expires Aug 31, 2026

    granted
  24. US 7101932

    Method for the preparation of 1-benzotriazolyl carbonate esters of poly (ethylene glycol)

    Nektar Therapeutics AL, Corporation Β· Granted Sep 5, 2006 Β· Expires Aug 31, 2026

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.